subcutaneous 24-hour infusion of foslevodopa/foscarbidopa improves motor symptoms in pd patients
Published 11 months ago • 4.6K plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
1:20
foslevodopa/foscarbidopa improves nocturia symptoms in patients with parkinson’s disease
-
3:31
emerging subcutaneous infusions for pd: efficacy & infusion site reactions
-
1:29
benefits and challenges associated with subcutaneous infusions for parkinson’s disease
-
1:18
interim results of sc foslevodopa/foscarbidopa in parkinson’s disease
-
1:20
video shows 'life-changing' transformation of parkinson's sufferer after new drug | swns
-
54:26
results and findings from the lixipark trial - professor olivier rascol
-
15:56
a duodopa journey
-
0:51
how can continuous dopaminergic delivery improve outcomes in pd?
-
1:27
updates on levodopa infusion therapies for advanced parkinson’s disease
-
18:15
long-acting, subcutaneous levodopa in parkinson's disease: is it safe?
-
3:02
improvements to levodopa-based treatments for parkinson’s disease
-
2:32
latest approaches to improve the delivery of levodopa
-
1:23
healthbeat: duopa for parkinson’s patients
-
1:06
upcoming advancements in subcutaneous levodopa therapy for pd
-
6:56
parkinson’s my journey with it and the duopa pump
-
9:12
what is duopa? sd 480p
-
1:13
extending the efficacy of levodopa in patients with parkinson’s disease
-
2:47
new treatment for parkinson's disease patients - focused ultrasound is safe and effective
-
0:51
emerging levodopa-based treatment strategies for pd: sc delivery
-
2:20
phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease